CAS: 936694-12-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Glesatinib REF: TR-G407030CAS: 936694-12-1 | - - - | 5.338,00 € | Mar 18 Jun 24 |
 | Glesatinib REF: 3D-LMB69412CAS: 936694-12-1 | Min. 95% | A consultar | Lun 17 Jun 24 |
 | Glesatinib REF: TM-T15384CAS: 936694-12-1 | 98% | 1.000,00 €~2.617,00 € | Mar 25 Jun 24 |
Glesatinib
Producto controladoCAS:936694-12-1
Fórmula:
C31H27F2N5O3S2
Forma y color:
White to Off-White Solid
Peso molecular:
619.705
Ref: TR-G407030
| 100mg | 5.338,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Junio de 2024
Glesatinib
CAS:936694-12-1
Glesatinib is a peptide that has been developed as a research tool to study the …
Fórmula:
C31H27F2N5O3S2
Pureza:
Min. 95%
Peso molecular:
619.7 g/mol
Ref: 3D-LMB69412
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 17 de Junio de 2024
Glesatinib
CAS:936694-12-1
Glesatinib is an orally active and potent dual inhibitor of MET/SMO. Glesatinib is also a …
Fórmula:
C31H27F2N5O3S2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
619.7
Ref: TM-T15384
| 25mg | 1.549,00 € | |
| 50mg | 2.038,00 € | |
| 100mg | 2.617,00 € |
Entrega estimada en Estados Unidos, el Martes 25 de Junio de 2024
